Real-world outcomes in patients with AML and MDS treated with Azacitidine

被引：0
|
作者：
Prusak, E. [1 ]
Lawes, M. [2 ]
Collins, A. [2 ]
机构：
[1] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[2] Norfolk & Norwich Univ Hosp, Haematol, Norwich, Norfolk, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
AML; Azacitidine; mds;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-PO-0
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [31] THE MDS/MPN PATIENTS TREATED WITH 5-AZACITIDINE: A CLINICAL REAL LIFE EXPERIENCE
    Riva, M.
    Molteni, A.
    Borin, L.
    Bernardi, M.
    Pellizzari, A.
    Freyrie, A.
    Della Porta, M.
    Nichelatti, M.
    Ravano, E.
    Quaresmini, G.
    Mariotti, J.
    Caramazza, D.
    Ubezio, M.
    Guarco, S.
    Gigli, F.
    Greco, R.
    Cairoli, R.
    HAEMATOLOGICA, 2015, 100 : 725 - 725
  • [32] Real-World Treatment Patterns and Outcomes with Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia
    Krishnamurthy, Pramila
    Houghton, Katherine
    Lorenz, Nicola
    Williams, Paula
    Currie, Lisa
    Vigil, Carlos E.
    Ziba, Nomthandazo
    Bello, Fareedat
    Sieluk, Jan
    Strocchia, Maria
    Li, Yeran
    Kapp-Schwoerer, Silke
    BLOOD, 2024, 144 : 2426 - 2426
  • [33] Continuity and efficacy of real-world use of azacitidine
    Usami, E.
    Kimura, M.
    Takenaka, S.
    Kanda, T.
    Teramachi, H.
    Yoshimura, T.
    PHARMAZIE, 2020, 75 (04): : 154 - 158
  • [34] Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib
    Passamonti, Francesco
    Korgaonkar, Siddhi
    Parikh, Rohan C.
    Chevli, Manoj
    Yucel, Aylin
    Rombi, Julien
    Jones, Shalon
    Zissler, Dorothy
    Davis, Keith L.
    Slaff, Samantha
    FUTURE ONCOLOGY, 2025, 21 (05) : 579 - 591
  • [35] Persistence, effectiveness, and real-world outcomes in psoriasis patients treated with secukinumab in Portugal
    Mendes-Bastos, Pedro
    Morais, Paulo
    Ferreira, Paulo
    Loureiro, Manuela
    Sanganha, Joaquina
    Santiago, Luis
    Basto, Antonio Sousa
    Henrique, Martinha
    DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [36] Pregnancy outcomes in patients treated with belimumab: Report from real-world experience
    Kao, Jui-Hung
    Lan, Ting-Yuan
    Lu, Cheng-Hsun
    Cheng, Chiao-Feng
    Huang, Yi-Min
    Shen, Chieh-Yu
    Hsieh, Song-Chou
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (05) : 963 - 968
  • [37] Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.
    Fawaz, Ali
    Tilley, Derek
    Karachiwala, Hatim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 307 - 307
  • [38] Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
    Aarup, Kathrine
    Rotbain, Emelie Curovic
    Enggaard, Lisbeth
    Pedersen, Robert Schou
    Bergmann, Olav Jonas
    Thomsen, Rasmus Heje
    Frederiksen, Mikael
    Frederiksen, Henrik
    Nielsen, Tine
    Christiansen, Ilse
    Andersen, Michael Asger
    Niemann, Carsten Utoft
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (05) : 646 - 654
  • [39] EVALUATION OF THE PREDICTIVE FACTORS OF MDS PATIENTS TREATED WITH AZACITIDINE
    Matsubara, E.
    Yamanouchi, J.
    Yakushijin, Y.
    Hato, T.
    Yasukawa, M.
    LEUKEMIA RESEARCH, 2015, 39 : S112 - S112
  • [40] Real-World Outcomes of Decitabine plus Venetoclax With IDH Inhibition for AML
    Kusiel, Justin
    Baratam, Praneeth
    Green, Kimberly
    Coltoff, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S297 - S297
12345